Disclosures No financial disclosures I have never consumed bath - - PowerPoint PPT Presentation

disclosures
SMART_READER_LITE
LIVE PREVIEW

Disclosures No financial disclosures I have never consumed bath - - PowerPoint PPT Presentation

11/4/2013 Disclosures No financial disclosures I have never consumed bath salts Rub-A-Dub-DIE: Bath Salts in the ED Eric Silman, MD Assistant Professor of Emergency Medicine UCLA Medical/Olive-View Emergency Medicine Residency The


slide-1
SLIDE 1

11/4/2013 1

Rub-A-Dub-DIE: Bath Salts in the ED

Eric Silman, MD

Assistant Professor of Emergency Medicine

UCLA Medical/Olive-View Emergency Medicine Residency

Disclosures

  • No financial disclosures
  • I have never consumed bath salts

The case that started it all…

slide-2
SLIDE 2

11/4/2013 2

Objectives: Three Questions

  • What are Bath Salts?
  • What do patients on Bath Salts look like?
  • What can you do about it?

What Are Bath Salts? What Are Bath Salts?

Synthetic Cathinones

slide-3
SLIDE 3

11/4/2013 3

Methylone Mephedrone MDPV

Catha edulis (“Khat”)

slide-4
SLIDE 4

11/4/2013 4

History and Legality

  • Early 2000’s: Europe
  • 2010: First US reports
  • 2011: DEA Schedule I
  • 2012: Federal Ban
  • “Designer Drug” concept
  • Federal Analog Act

What do patients on Bath Salts look like?

slide-5
SLIDE 5

11/4/2013 5

+

x 10

Sympathomimetic

  • Agitation, seizure
  • Tachycardia, HTN
  • Mydriasis, diaphoresis

Serotonin

  • Hyperpyrexia
  • Hyponatremia
  • Hallucination

Severe Toxicity

  • Psych: Agitated delirium, psychosis
  • CNS: Seizure, cerebral edema
  • Cardiovascular: Myocardial ischemia,

hemodynamic collapse

  • Renal: Rhabdomyolysis, AKI

Seizure, coma, death.

259 exposures

213 age 13-39 50% ingested 33% insufflated

219 referred to ED 86 (33%) discharged

15 (6%) intubated 29 (11%) admitted to non-ICU 22 (9%) admitted to psych 35 (14%) admitted to ICU 2 (1%) died

slide-6
SLIDE 6

11/4/2013 6

2,018 exposures 1,633 included

142 (8.7%) intubated 1379 (88.5%) intentional abuse 956 (58.5%) received BZD 253 (15.5%) “major effect” 9 (0.6%) died

What can you do about it? Diagnosis

  • History and physical exam
  • Fingerstick glucose
  • Laboratory testing
  • ECG and monitoring
slide-7
SLIDE 7

11/4/2013 7

Therapy

  • ABC’s
  • Aggressive cooling
  • Benzodiazepines
  • Antipsychotics?
  • Dantrolene?

Review: Three Answers

  • What are “Bath Salts?”
  • What do patients on Bath Salts look like?
  • What can you do about it?

Acknowledgements and References

  • Thanks

– Craig Smollin, MD – Kent Olson, MD

  • Selected references

Fass JS, Fass AD, Garcia AS. Synthetic cathinones (bath salts): legal status and patterns of abuse. Ann

  • Pharmacotherapy. 2012 Mar 46: 436-41.

Warrick BJ et. al. Synthetic cathinones a 9-state analysis of designer stimulant “Bath Salts.” Ann Emerg Med 2013.

Thank You